223 related articles for article (PubMed ID: 2697177)
21. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
[TBL] [Abstract][Full Text] [Related]
22. Reactivity of a mouse/human chimeric anti-GM2 antibody KM966 with brain tumors.
Dohi T; Nakamura K; Hanai N; Taomoto K; Oshima M
Anticancer Res; 1994; 14(6B):2577-81. PubMed ID: 7872684
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneity and clonal variation related to cell surface expression of a mouse lung tumor-associated antigen quantified using flow cytometry.
Bahler DW; Lord EM; Kennel SJ; Horan PK
Cancer Res; 1984 Aug; 44(8):3317-23. PubMed ID: 6378365
[TBL] [Abstract][Full Text] [Related]
24. [Immunohistological diagnosis of human and experimental brain tumors using antiserum to astroprotein (author's transl)].
Yoshimine T; Ushio Y; Hayakawa T; Morimoto K; Mori T; Mogami H
No To Shinkei; 1979 Jan; 31(1):85-93. PubMed ID: 371641
[No Abstract] [Full Text] [Related]
25. Patterns of reactivity with anti-glycolipid antibodies in human primary brain tumors.
Li J; Pearl DK; Pfeiffer SE; Yates AJ
J Neurosci Res; 1994 Oct; 39(2):148-58. PubMed ID: 7530777
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical localization of prostate carcinoma-associated antigens.
Wright GL; Beckett ML; Starling JJ; Schellhammer PF; Sieg SM; Ladaga LE; Poleskic S
Cancer Res; 1983 Nov; 43(11):5509-16. PubMed ID: 6193873
[TBL] [Abstract][Full Text] [Related]
27. Analysis of antigenic expression by primary and autologous metastatic human sarcomas using murine monoclonal antibodies.
Roth JA; Restrepo C; Scuderi P; Baldwin RW; Reichert CM; Hosoi S
Cancer Res; 1984 Nov; 44(11):5320-5. PubMed ID: 6386149
[TBL] [Abstract][Full Text] [Related]
28. [Immunohistological analysis of infiltrating lymphocyte subpopulations in gliomas and metastatic brain tumors].
Saito T; Tanaka R; Kouno M; Takai N; Yoshida S; Hara N; Washiyama K; Sekiguchi K; Kumanishi T
No To Shinkei; 1987 Apr; 39(4):339-45. PubMed ID: 2439110
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal antibody ONS-M21 recognizes integrin alpha3 in gliomas and medulloblastomas.
Kishima H; Shimizu K; Tamura K; Miyao Y; Mabuchi E; Tominaga E; Matsuzaki J; Hayakawa T
Br J Cancer; 1999 Jan; 79(2):333-9. PubMed ID: 9888477
[TBL] [Abstract][Full Text] [Related]
30. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
Tong AW; Lee J; Stone MJ
Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
[TBL] [Abstract][Full Text] [Related]
31. [Histological and molecular classification of gliomas].
Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
[TBL] [Abstract][Full Text] [Related]
32. Murine monoclonal antibodies cytotoxic to human glioma cells in vitro.
Sánchez-Gómez MV; Conde-Guerri B; Sinués-Porta E; Matute C
Histol Histopathol; 1992 Oct; 7(4):619-24. PubMed ID: 1457984
[TBL] [Abstract][Full Text] [Related]
33. Heterogeneity of keratin intermediate filaments expression in human glioma cell lines.
Máciková I; Perzelová A; Mráz P; Steno J; Bízik I
Neoplasma; 1999; 46(6):390-3. PubMed ID: 10732869
[TBL] [Abstract][Full Text] [Related]
34. Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumors.
Patsouris E; Stocker U; Kallmeyer V; Keiditsch E; Mehraein P; Stavrou D
Anticancer Res; 1988; 8(4):537-44. PubMed ID: 3052245
[TBL] [Abstract][Full Text] [Related]
35. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
36. Long-term passage results of glioma cells and their cell kinetics.
Matsumura K; Kawamoto K
Hum Cell; 1994 Sep; 7(3):158-66. PubMed ID: 7873500
[TBL] [Abstract][Full Text] [Related]
37. Expression of non-glial intermediate filament proteins in gliomas.
Hirato J; Nakazato Y; Ogawa A
Clin Neuropathol; 1994; 13(1):1-11. PubMed ID: 7518371
[TBL] [Abstract][Full Text] [Related]
38. Identification of gliomas by morphological and immunocytochemical analysis in cell cultures.
Fazekas I; Kerekes E; Hegedús B; Nyáry I
Ideggyogy Sz; 2002 May; 55(5-6):173-9. PubMed ID: 12122877
[TBL] [Abstract][Full Text] [Related]
39. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
Laterra J; Nam M; Rosen E; Rao JS; Lamszus K; Goldberg ID; Johnston P
Lab Invest; 1997 Apr; 76(4):565-77. PubMed ID: 9111517
[TBL] [Abstract][Full Text] [Related]
40. HEA 125 and Ber EP4: two monoclonal anti-epithelial, non-cytokeratin antibodies distinguishing metastatic carcinomas from glial tumors.
Gottschalk J; Jautzke G; Zimmer C; Cervós-Navarro J
Clin Neuropathol; 1993; 12(2):68-72. PubMed ID: 7682900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
